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Introduction
In the last decade, the market of nuclear medicine instrumenta-
tion has developed dramatically. On the one hand, highly sophis-
ticated equipment has been introduced, which allows procedures
like transmission measurement for image fusion, attenuation cor-
rection, scatter correction and automatic body contouring. On the
other hand there is a significant demand for imaging facilities at
lower costs for routine diagnostics. Since both tendencies are ac-
companied by an increasing number of mergers, the number of
industry partners has been decreasing continuously over the last
few years.
The present paper focuses on basic requirements for state-
of-the-art gamma cameras and briefly discusses upcoming de-
velopments in the field of nuclear medicine instrumentation.
Nuclear medicine instrumentation
General nuclear medicine
The basic instrument of a state-of-the-art nuclear medicine de-
partment is the dual-headed whole-body SPECT system. This is
the result of technical development in the past decade. Currently,
there are two classes of this system available for the nuclear med-
icine physician:
 The class of high-end gamma cameras offers hardware
and software solutions for attenuation correction based on trans-
mission scanning with external radiation sources. This is complet-
ed by software solutions for scatter correction. Moreover, solu-
tions for combined SPECT/PET or SPECT/CT devices have been
presented by the industry. Although this development significant-
ly stimulated scientific interest in technical problems, these devic-
es inherently have two serious drawbacks: they are not yet suffi-
ciently validated, and they are rather expensive.
 The other class of nuclear medicine devices was designed
for the basic requirement of everyday routine patient management.
For this purpose, gamma cameras should provide high-quality
data acquisition for all organs and all clinical questions, and should
be simple to use for the technician. Therefore, both the hardware
and the acquisition software should provide high stability in ev-
eryday performance. A further important requirement is that data
processing should be easily possible with any software system,
whatever the users preferred choice, and they should be offered
for a moderate price. Furthermore, the customer service should have
short reaction times at acceptable costs. The latter can be ensured
by the vendor, when using fairly standardised electronic and me-
chanical parts, at best for a whole family of gamma cameras.
Nuclear cardiology
Nuclear cardiology has always been an important field of diag-
nostic nuclear medicine. Therefore, two-headed gamma camer-
as have quickly become the state-of the-art equipment since they
allow the reduction of acquisition time, an increase in patient
throughput, and a reduction in the frequency of motion arte-
facts. For myocardial perfusion SPECT studies, both detectors
of the two-headed gamma camera should be allowed to move
into a position of 90 or 102 degrees to each other. In a busy nu-
clear cardiology department, a fixed-angled dual-headed system
can be used as an alternative. The striking advantages of such
dedicated equipment are the smaller detectors, the more simple
mechanics and, in consequence, the lower costs. Gated myocar-
dial SPECT provides additional information about global ventricu-
lar function, regional wall motion and myocardial thickening. Re-
cently, the method has become widely accepted and should be
implemented for routine patient management, even in low-cost
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equipment. On the other hand, transmission data for absorption
measurements are still under clinical evaluation and need further
evaluation. The clinical benefit of correction protocols may be ham-
pered by and has to be weighed against the introduction of new
artefacts.
Nuclear neurology
In state-of-the-art brain SPECT, triple-headed gamma cameras
have become standard in leading edge nuclear medicine depart-
ments. However, these gamma cameras were designed original-
ly for SPECT studies of all parts of the human body. Therefore,
they are usually equipped with large field of view detector heads,
and, thus, inherently have problems in minimising the rotational
radius within the contours of the patients·shoulders. Although
these problems may be overcome (at least in part) by using ded-
icated brain SPECT collimators, such as ultra-high-resolution (mag-
nifying) fan beam collimators, image quality can be increased fur-
ther by dedicated brain SPECT systems built from numerous sin-
gle small detectors arranged in a ring (e.g. CereSPECT). Howev-
er, this ultra-specialised system is rather expensive. An interest-
ing compromise has been presented recently by the introduction
of the first commercial low-cost 4-headed gamma camera. This
device, dedicated for brain SPECT imaging, combines the ad-
vantage of an excellent image quality (Figs. 16) (due to the small
rotational radius of about 13 cm) with a reasonable price. This
system offers the opportunity to increase the clinical acceptance
of brain SPECT studies significantly despite exquisite morpholog-
ic imaging devices with high geometric resolution provided by
todays state-of-the-art MRI systems.
Positron emission tomography
Positron emission tomography (PET) is the most sophisticated
imaging technology of modern nuclear medicine. For clinical in-
vestigations, the full ring PET scanner with 3D acquisition facilities
has become the standard equipment. Recent developments are
directed towards a further improvement of geometric resolution,
increasing the count rate capability by using new crystal materials
such as LSO, and a combined PET/CT scanner.
One of the most exciting areas (for research applications) is
the introduction of new small animal PET systems, that provide
a system resolution of as little as 2 mm, and new designs that
allow the resolution of a single microlitre. This development will
close the gap between autoradiography in rats and functional
imaging in patients. While 100 years ago c e l l u l a r  patholo-
gy was introduced by Virchow using histomo r p h o l o g i c a l
methods, we have now come down to defining pathology on a
biochemical level when using f u n c t i o n a l  d e f i n e d
m o l e c u l a r  i m a g i n g  modalities of nuclear medicine.
Future direction of technological develop-
ments
The direction of developments is usually driven by industry and
their understanding of the needs of the market. Concerning the
need for validation, some of the future challenges of nuclear med-
icine instrumentation will be listed:
 Image fusion has shown up a lot in scientific life and may
have a great impact on the acceptance of nuclear medicine re-
sults by the referring clinician. On the other hand, regular and
consistent change of image interpretation in routine patient care
still has to be proved.
 Transmission in cardiac SPECT with absorption correc-
tion may induce artefacts, any clinical benefit still has to be
validated.
 Additional scatter correction is needed to obtain results in
Becquerels rather than in counts, and there is still possibly a long
way to go.
Conclusion
Industry-driven, leading-edge equipment in nuclear medicine push-
es the frontier of what is achievable in molecular-defined imaging
 becoming a valuable tool for the molecular biologist. On the
other hand, for patient care all new equipment features need val-
idation to prove their clinical utility. In the time of cost reduction
and ever-increasing need for efficiency new hardware has to be
both reliable and cost-effective at the same time. For these goals
(new) enterprises should be encouraged.
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Figure 1. 58-year-old female patient with acute complete occlusion of the right internal cerebral artery, accompanied by hemiparesis on the left side.
A 70%-stenosis of the left internal cerebral artery was known in the patients history. SPECT images were obtained under rest and under pharmacological
stress (using a carbonic anhydrase inhibitor) after application of 250 and 750 MBq 99mTc-ECD, respectively. The stress study revealed a larger perfusion
deficit in the right fronto-parietal cortex when compared with the rest study, thereby indicating an impaired perfusion reserve. Additionally, a crossed
cerebellar diaschisis was found.
Figure 2. 64-year-old patient with complete infarction of the left medial cerebral artery 10 days earlier. SPECT images were obtained 10 minutes and 2 hours
after the injection of 200 MBq 123I-iomazenil. Note the increased (luxury) perfusion in the left parietal cortex in the early images and a corresponding decrease
of benzodiazepine receptor density in the late images. Thus, damage of cortical integrity was proved in the left parietal area.
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Figure 3. 10-year-old patient with the diagnosis of an anaplastic astrocytoma III° in the right thalamus. The patient was treated initially with chemo- and
radiotherapy until 6 months earlier. The first SPECT acquired 2 hours after the application of 100 MBq 201Tl in May 2000 showed a physiological tracer
distribution. In contrast, the same study performed three months later revealed a relapse in the right hemisphere.
Figure 4. 19-year-old patient with bilateral tremor of the hands. SPECT images were obtained 3 hours after the application of 200 MBq 123I-FP-CIT, a co-
caine derivative. This examination was performed in order to differentiate Parkinsonian syndrome from essential tremor. Note the physiological tracer up-
take in both striata pointing towards an essential tremor.
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Figure 5. 65-year-old patient with pronounced left-sided Parkinson symptoms for 8 years. The patients symptoms started with marked tremor, and hy-
pokinesia and dysbalance 3 years earlier. SPECT images were obtained 3 hours after the application of 200 MBq 123I-FP-CIT. Note the bilateral loss of
presynaptic dopamine transporter density in the putamen and a marked reduction in the right caudate nucleus, which is consistent with an advanced
form of Parkinsons disease.
Figure 6. 53-year-old patient with pronounced left-sided akinetic-rigid syndrome. SPECT images were obtained one hour after the application of
200 MBq 123I-IBZM. Note the significantly reduced dopamine D2 receptor density in the right striatum and in the left putamen, which is consistent with
multiple-system-atrophy.
